# The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults

> **NCT06224296** · NA · UNKNOWN · sponsor: **Shanghai Cell Therapy Group Co.,Ltd** · enrollment: 250 (estimated)

## Conditions studied

- Sub-healthy
- Hyperlipidemia
- Toxic Metal Ions Accumulation

## Interventions

- **DEVICE:** DFPP
- **DEVICE:** DFPP
- **DEVICE:** DFPP

## Key facts

- **NCT ID:** NCT06224296
- **Lead sponsor:** Shanghai Cell Therapy Group Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06224296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06224296, "The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06224296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*